• Investor Relations
  • PHYSICIAN PORTAL
  • Contact Us
  • Corporate Website
BioStem Technologies, Inc
Investor relations
  • Overview
  • News
  • Presentation
  • Financials
    • SEC Filings
    • Quarterly Results
  • Stock Info
  • Governance
    • Management Team
    • Board of Directors
    • Governance Documents
    • Board Committees
  • More
    • Contact IR
    • Events
    • Analysts
    • Investor Email Alerts
    • FAQs
  • Corporate Website
Select Page

Governance Documents

Investor Relations

Governance Documents

Corporate Governance Guidelines
Audit Committee Charter
Corporate Governance & Nominating Committee Charter
Compensation Committee Charter
Code of Conduct
BioStem Technologies, Inc. products are registered under the regulations of the U.S. Food and Drug Administration (FDA) governing the manufacture and distribution of Human Tissue Products. They are marketed as structural tissue allografts for homologous use and are used by physicians as barriers, wound coverings, conduits, and/or cushions in the treatment of their patients.
  • Our Technologies
    • CryoTek®
    • SteriTek®
    • BioRetain®
    • Procurement
  • Our Products
  • Advanced Surgical Care
    • Clarix® 1K
  • Advanced Wound Care
    • Neox® 1K
    • Neox® RT
    • Vendaje AC®
    • American Amnion ACTM
  • Clinical Evidence
  • Company
    • About Us
    • Leadership
    • Facilities & Quality
    • News & Events
    • Careers
  • Resources
    • AATB Accreditation
    • FDA Registration
    • State Registrations
    • Application Guides
  • Patents
  • Investor Relations
  • PHYSICIAN PORTAL
  • Contact Us
  • Corporate Website
  • X
  • Instagram
  • RSS

© 2026 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.

Terms of UsePRIVACY NOTICE COOKIE POLICY Do Not Sell or Share My Personal Information
Disclaimer

You are about to review presentations, reports and/or filings of BioStem Technologies, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. BioStem Technologies, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by BioStem Technologies, Inc.

I Accept I Decline